Impact BioMedical to begin efficacy testing of Pan-Coronavirus vaccine under newly formed subsidiary
ROCHESTER: Impact BioMedical Inc. has formed a new wholly owned subsidiary, Innate Immune Inc., to initiate efficacy testing of a pancoronavirus vaccine, a special type of vaccine designed to protect against multiple coronaviruses. “Highly pathogenic human coronaviruses are continuously emerging…